Share of Clicks for top 10 US Pharma & Biotech Pharmacology brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| lilly.com | 21.92 |
| ro.co | 15.46 |
| wegovy.com | 5.49 |
| forbes.com | 5.42 |
| bmimd.com | 4.94 |
| goodlifemeds.com | 3.98 |
| goodrx.com | 2.52 |
| joinamble.com | 2.02 |
| ivyrx.com | 1.68 |
| webmd.com | 1.53 |
| others | 35.04 |
- lilly.com - 21.92%
- ro.co - 15.46%
- wegovy.com - 5.49%
- forbes.com - 5.42%
- bmimd.com - 4.94%
- goodlifemeds.com - 3.98%
- goodrx.com - 2.52%
- joinamble.com - 2.02%
- ivyrx.com - 1.68%
- webmd.com - 1.53%
- others - 35.04%
Copyright © Adthena. All rights reserved.
In the PPC landscape, Lilly.com leads with 21.92% click share, followed by Ro.co at 15.46%. Others collectively hold 35.04%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Pharmacology brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | lilly.com | ro.co | bmimd.com | forbes.com | goodlifemeds.com | wegovy.com | citizenmeds.com | ivyrx.com | joinamble.com | webmd.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/08/01 | 19.26% | 19.07% | 5.33% | 10.35% | 1.58% | 1.97% | 2.63% | 1.74% | 2.33% | 4.77% |
| 2026/08/02 | 10.71% | 18.63% | 9.93% | 8.94% | 8.69% | 1.99% | 2.86% | 6.12% | 0.4% | 2.48% |
| 2026/08/03 | 13.01% | 14.92% | 9.41% | 4.24% | 7.11% | 2.1% | 4.01% | 1.92% | 3.78% | 3.17% |
| 2026/08/04 | 27.01% | 14.51% | 1.76% | 7.14% | 4.73% | 2.21% | 0.37% | 1.19% | 1.53% | 1.97% |
| 2026/08/05 | 11.67% | 15.44% | 7.69% | 5.39% | 6.59% | 2.04% | 4.06% | 3.1% | 4.65% | 0.45% |
| 2026/08/06 | 21.64% | 22.48% | 1.57% | 6.43% | 3.14% | 2.37% | 0.14% | 0.93% | 1.84% | 0.25% |
| 2026/08/07 | 23.29% | 22.12% | 5.99% | 6.36% | 4.19% | 2.35% | 2.04% | 0.67% | 2.86% | 0.44% |
| 2026/08/08 | 11.54% | 16.42% | 12.09% | 5.84% | 9.88% | 1.19% | 4.11% | 4.06% | 4.99% | 2.79% |
| 2026/08/09 | 19.26% | 17.93% | 6.58% | 5.48% | 6.57% | 2.74% | 2.11% | 2.09% | 2.77% | 0.46% |
| 2026/08/10 | 25.76% | 13.51% | 9.7% | 7.27% | 4.42% | 1.67% | 1.89% | 2.26% | 3.24% | 0.43% |
| 2026/08/11 | 18.58% | 20.15% | 1.77% | 6.52% | 8.45% | 2.38% | 0.07% | 3.3% | 4.04% | 1.44% |
| 2026/08/12 | 22.83% | 20.4% | 6.5% | 7.6% | 6.43% | 2.11% | 3% | 1.8% | 1.4% | 1.21% |
| 2026/08/13 | 28.97% | 18.02% | 5.91% | 5.46% | 5.59% | 1.72% | 0.02% | 0.7% | 0.94% | 0.16% |
| 2026/08/14 | 23.23% | 15.93% | 10.4% | 5.69% | 8.37% | 1.63% | 3.63% | 2.43% | 4.27% | 0.49% |
| 2026/08/15 | 36.87% | 13.52% | 4.68% | 9.92% | 2.45% | 2.29% | 0% | 1.21% | 1.95% | 0.53% |
| 2026/08/16 | 28.15% | 16.56% | 8% | 5.56% | 6.09% | 2.11% | 2.58% | 1.45% | 3.48% | 0.79% |
| 2026/08/17 | 28.66% | 15.51% | 4.62% | 8.21% | 3.57% | 2.58% | 0% | 0.75% | 2.02% | 2.63% |
| 2026/08/18 | 24.9% | 21.11% | 10.99% | 4.29% | 5.99% | 1.83% | 1.89% | 1.59% | 3.04% | 0.43% |
| 2026/08/19 | 33.1% | 25.39% | 2.1% | 8.09% | 1.1% | 2.69% | 0.4% | 0.87% | 2.14% | 0.42% |
| 2026/08/20 | 29.48% | 21.48% | 11.21% | 4.78% | 4.98% | 1.76% | 2.92% | 0.3% | 2.97% | 1.12% |
| 2026/08/21 | 36% | 15.18% | 2.35% | 7.95% | 3.54% | 2.76% | 0.6% | 0.41% | 2.1% | 0.83% |
| 2026/08/22 | 32.97% | 18.14% | 1.06% | 12.24% | 0.9% | 2.35% | 0.59% | 0.63% | 0.96% | 6.53% |
| 2026/08/23 | 29.01% | 16.95% | 5.15% | 6.15% | 4.52% | 1.96% | 2.02% | 2.33% | 1.99% | 3.26% |
| 2026/08/24 | 34.34% | 18.86% | 8.8% | 4.23% | 2.65% | 2.53% | 0.08% | 0.42% | 1.09% | 0.35% |
| 2026/08/25 | 29.26% | 19.11% | 4.5% | 5.62% | 4.72% | 2.38% | 2.23% | 3.11% | 2.4% | 0.39% |
| 2026/08/26 | 28.77% | 22.64% | 5.06% | 2.7% | 2.83% | 2.49% | 1.97% | 3.96% | 3% | 0.84% |
| 2026/08/27 | 30.75% | 16.73% | 8.65% | 4.3% | 5.4% | 1.83% | 3.72% | 1.75% | 3.17% | 0.88% |
| 2026/08/28 | 40.06% | 16.53% | 1.14% | 8.18% | 0.6% | 2.76% | 0.08% | 0.46% | 0.86% | 2.63% |
| 2026/08/29 | 37.83% | 15.58% | 1.2% | 4.65% | 1.4% | 3.36% | 0.28% | 0.9% | 1.56% | 3.34% |
| 2026/08/30 | 28.76% | 25.1% | 4.18% | 3.43% | 7.17% | 2.41% | 0.01% | 0.29% | 0.65% | 2.58% |
| 2026/08/31 | 31.01% | 18.78% | 6.91% | 5.43% | 4.89% | 2.17% | 1.96% | 1.8% | 1.08% | 0.29% |
- lilly.com
- ro.co
- bmimd.com
- forbes.com
- goodlifemeds.com
- wegovy.com
- citizenmeds.com
- ivyrx.com
- joinamble.com
- webmd.com
Copyright © Adthena. All rights reserved.
In August 2026, lilly.com led with fluctuating spend, peaking at 40.06% on the 28th. Ro.co maintained steady mid-range values, while bmimd.com and forbes.com showed lower, varied trends. The month concluded with lilly.com dominating.
Competitor Count for US Pharma & Biotech Pharmacology
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/08/01 | 389 |
| 2026/08/02 | 390 |
| 2026/08/03 | 387 |
| 2026/08/04 | 387 |
| 2026/08/05 | 355 |
| 2026/08/06 | 334 |
| 2026/08/07 | 341 |
| 2026/08/08 | 320 |
| 2026/08/09 | 337 |
| 2026/08/10 | 333 |
| 2026/08/11 | 354 |
| 2026/08/12 | 357 |
| 2026/08/13 | 346 |
| 2026/08/14 | 362 |
| 2026/08/15 | 350 |
| 2026/08/16 | 348 |
| 2026/08/17 | 341 |
| 2026/08/18 | 331 |
| 2026/08/19 | 331 |
| 2026/08/20 | 345 |
| 2026/08/21 | 350 |
| 2026/08/22 | 356 |
| 2026/08/23 | 354 |
| 2026/08/24 | 353 |
| 2026/08/25 | 333 |
| 2026/08/26 | 331 |
| 2026/08/27 | 332 |
| 2026/08/28 | 335 |
| 2026/08/29 | 340 |
| 2026/08/30 | 340 |
| 2026/08/31 | 324 |
Copyright © Adthena. All rights reserved.
August began with 389 advertisers, fluctuating throughout the month, peaking at 390, and ending at 324.
